DOAC management in VTE patients with cancer

Are you a healthcare professional (HCP) involved in the management of patients with cancer-associated venous thromboembolism (Ca-VTE)?

Join our faculty for a webinar bringing together expert guidance from a variety of specialities, providing an update on the latest clinical data together with an overview of the evolving guideline recommendations for the use of direct-acting oral anticoagulants (DOAC) in this uniquely challenging patient population.

Understand the challenges of treating cancer patients who present with VTE and the limitations of traditional standards of care. Explore the latest data from the key trials shaping the direction of management in this unique patient population.

Join our expert faculty in a live, interactive discussion of a Ca-VTE patient scenario highlighting the practical challenges and considerations around anticoagulation therapy throughout the patient journey.

20:00 Uhr
Start

3 min
Welcome and objectives
Giancarlo Agnelli

10 min
VTE in patients with cancer – a unique population
Jean Connors

15 min
Evolution of anticoagulation for the treatment of VTE in patients with cancer
Giancarlo Agnelli

40 min
Understanding the journey of the patient with cancer and VTE – an interactive audience discussion
Andrés Muñoz Martin, Giancarlo Agnelli Jean Connors Masataka Ikeda

5 min
General Q&A

2 min
Summary and close
Giancarlo Agnelli

21:15 Uhr
End